PhRMA Seeks Quick Win In 340B Orphan Drug Suit
Pharmaceutical Research and Manufacturers of America on Wednesday urged a D.C. federal judge to ax a regulation involving discounts for orphan drugs, setting the stage for an important decision on the...To view the full article, register now.
Already a subscriber? Click here to view full article